Skip to Main content Skip to Navigation
Journal articles

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

Abstract : Melanoma reactive CTL were obtained by stimulating PBL from a melanoma patient in remission since 1994 following adjuvant TIL immunotherapy, with the autologous melanoma cell line. They were cloned by limiting dilution. One CTL clone recognized melanoma cell lines expressing tyrosinase and the B*4002 molecule, either spontaneously or upon transfection. We demonstrated that this clone recognizes the tyrosinase-derived nonapeptide 316-324 (ADVEFCLSL) and the overlapping decapeptide 315-324 (SADVEFCLSL). We derived two distinct additional speciWc CTL clones from this same patient that were also reactive against B*4002 melanoma cell lines, suggesting a relative diversity of this speciWc repertoire in this patient. Stimulating PBMC derived from four additional B*4002 melanoma patients with the tyrosinase 316-324 nonapeptide induced the growth of speciWc cells for two of the patients, demonstrating the immunogenicity of this new epitope. Our data show that this nonapeptide is a new tool that could be used to generate melanoma-speciWc T cells for adoptive immunotherapy or serve as a peptide vaccine for HLA-B*4002 melanoma patients.
Complete list of metadatas

Cited literature [37 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02481995
Contributor : Nathalie Labarriere <>
Submitted on : Monday, February 17, 2020 - 5:39:29 PM
Last modification on : Friday, June 19, 2020 - 3:08:56 AM
Long-term archiving on: : Monday, May 18, 2020 - 6:10:56 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Yann Godet, Annabelle Bonnin, Yannik Guilloux, Virginie Vignard, Dirk Schadendorf, et al.. A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients. Cancer Immunology, Immunotherapy, Springer Verlag, 2009, 58 (2), pp.271 - 280. ⟨10.1007/s00262-008-0551-0⟩. ⟨inserm-02481995⟩

Share

Metrics

Record views

86